US Grants.gov · Geschlossen

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Amtliche Aufrufseite ↗

No summary published by the source. Read the official page.

Änderungsverlauf

First seen 28 Sept 2026, last checked 22 Nov 2026. 20 recorded versions.

  • 21 Nov 2026 · 41a7e3d83e8d
  • 19 Nov 2026 · 0c6159ec2fe3
  • 22 Oct 2026 · 359777278c0c
  • 21 Oct 2026 · a51e80f9e10e
  • 19 Oct 2026 · 0f90cba4f4f1
  • 18 Oct 2026 · 0b8cabc78627
  • 17 Oct 2026 · 539413d1d23a
  • 16 Oct 2026 · 2f5da843a38b
  • 15 Oct 2026 · 3d2e1d370c57
  • 14 Oct 2026 · 5ee746b27405
  • 13 Oct 2026 · 359777278c0c
  • 12 Oct 2026 · a51e80f9e10e
  • 11 Oct 2026 · df2a5433c399
  • 10 Oct 2026 · 9b5b4f5cf35d
  • 09 Oct 2026 · bddd9777c4d7
  • 08 Oct 2026 · 851da09faad7
  • 07 Oct 2026 · bcf8a5580638
  • 06 Oct 2026 · 8de5a2ff0aa3
  • 05 Oct 2026 · 7a834442666b
  • 04 Oct 2026 · a51e80f9e10e

Report a problem with this record · How data is produced